Navigation Links
Katie Hood Appointed Chief Executive Officer of The Michael J. Fox Foundation

- Key Architect of Foundation's Strategy Will Build On and Expand Transformational Approach -

NEW YORK, Dec. 14 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) today announced the appointment of Katie Hood as chief executive officer.

Ms. Hood, who joined the Foundation in September 2002, has been serving as interim CEO since October. As chief executive officer, she will build on the Foundation's strategy of inserting itself proactively into the research process to advance scientific breakthroughs, including the expansion of current initiatives to:

-- validate promising drug targets, thereby opening new opportunities for drug development;

-- increase investment in various stages of pre-clinical research and chaperoning pre-clinical hits from stage to stage;

-- selectively support clinical projects with the potential to improve patients' lives in the near-term; and

-- drive high-risk, high-reward attempts to uncover new research tools such as biomarkers.

Ms. Hood stated, "The Michael J. Fox Foundation has evolved into an organization willing to do whatever it takes to accelerate life-transforming treatments for Parkinson's patients - going beyond innovative funding mechanisms to work to change a flawed system that too often fails to translate research into results. Over the past seven years, we have built a unique expertise about Parkinson's research that we intend to leverage for impact over the coming months and years. Our capital should be -- and will be -- used to drive progress in ways that other funding sources are not."

David Golub, chairman of the Board of Directors of The Michael J. Fox Foundation, said: "We are committed to a strategy of working relentlessly to close critical gaps in the process of moving potential treatments from the laboratory to Parkinson's patients, and have worked with Katie and the entire executive team to develop a compelling vision of how that approach should be enhanced and extended for greater impact. The Board is confident that Katie is the right person to lead the MJFF forward and is sure that our efforts will result in scientific breakthroughs that ultimately translate into novel and effective therapies."

Ms. Hood will continue to provide day-to-day management and oversight of all Foundation activities and will specifically oversee fundraising, the Foundation's research team and communications, administration and financial management. Ms. Hood will report to the Board of Directors.

Before October of this year, Ms. Hood had served as deputy CEO of MJFF and, earlier, as vice president of research programs. Prior to joining the Foundation, Ms. Hood was employed as a consultant at Bain & Company in New York City, doing work in the consumer products, financial services, and nonprofit sectors. She has also served as an analyst in the Credit Department of Goldman, Sachs & Co., and as a program coordinator with Duke University's Hart Leadership Program. Ms. Hood graduated from Harvard Business School and holds a BA in Public Policy Studies from Duke University in Durham, North Carolina. A full biosketch is available at

About The Michael J. Fox Foundation

Founded in 2000, The Michael J. Fox Foundation for Parkinson's Research is dedicated to ensuring the development of a cure for Parkinson's disease within this decade through an aggressively funded research agenda. The Foundation has funded $100 million in research to date.

SOURCE Michael J. Fox Foundation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Katie Lee Joel to Conduct Cooking Demonstration for Local Patients With Chronic Kidney Disease
2. Katie Hood Appointed Interim Chief Executive Officer of Michael J. Fox Foundation
3. Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
4. William Moore Appointed to IRIDEX Board of Directors
5. Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
6. Theodore A. Boutacoff Appointed President & CEO of IRIDEX
7. James B. Hawkins Appointed to IRIDEX Board of Directors
8. Bryan R. Rogers Appointed President of Far West Division
9. Catholic Health Association Disappointed by Failure to Override SCHIP Veto
10. Steven M. Safyer, MD, Appointed President and CEO of Montefiore Medical Center
11. Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from reveals that behind ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... PARK RIDGE, Ill. and INDIANAPOLIS ... caliber of students receiving a Lilly Diabetes Tomorrow,s Leaders ... hands. The 2016 scholarship winners, announced today online at ... refused to let type 1 diabetes stand in the ... Lilly Diabetes has supported the Foundation,s scholarship program since ...
(Date:6/23/2016)... 23, 2016 Revolutionary technology includes ... Oticon , industry leaders in advanced audiology and hearing ... Oticon Opn ™, the world,s first internet connected hearing ... IoT devices.      (Photo: ... number of ,world firsts,: , TwinLink™ - ...
(Date:6/23/2016)... , June 23, 2016 The vast ... an outpatient dialysis facility.  Treatments are usually 3 times ... hours per visit, including travel time, equipment preparation and ... patient, but especially grueling for patients who are elderly ... a skilled nursing and rehabilitation centers for some duration ...
Breaking Medicine Technology: